Affordable Access

deepdyve-link
Publisher Website

Infliximab treatment of intravenous immunoglobulin-resistant Kawasaki disease.

Authors
  • Burns, Jane C1
  • Best, Brookie M
  • Mejias, Asuncion
  • Mahony, Lynn
  • Fixler, David E
  • Jafri, Hasan S
  • Melish, Marian E
  • Jackson, Mary Anne
  • Asmar, Basim I
  • Lang, David J
  • Connor, James D
  • Capparelli, Edmund V
  • Keen, Monica L
  • Mamun, Khalid
  • Keenan, Gregory F
  • Ramilo, Octavio
  • 1 Department of Pediatrics, University of California San Diego School of Medicine and Rady Children's Hospital San Diego, La Jolla, CA, USA.
Type
Published Article
Journal
The Journal of pediatrics
Publication Date
December 2008
Volume
153
Issue
6
Pages
833–838
Identifiers
DOI: 10.1016/j.jpeds.2008.06.011
PMID: 18672254
Source
Medline
License
Unknown

Abstract

Both infliximab and a second IVIG infusion were safe and well tolerated in the subjects with KD who were resistant to standard IVIG treatment. The optimal management of patients resistant to IVIG remains to be determined.

Report this publication

Statistics

Seen <100 times